N-(2-ethoxyphenyl)-N'-(4-isododecylphenyl)oxamide

Endpoint summary

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

20 July - 17 August 2011

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Guideline-conform study under GLP without deviations.

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Harlan Laboratories B.V.; AD Horst, The Netherlands
- Age at study initiation: 8-9 weeks
- Weight at study initiation: 18.1 - 20.1 g
- Housing: in groups in Macrolon Type II / III cages with wire mesh top with granulated soft wood bedding
- Diet: pelleted standard diet (Harlan Laboratories B.V., Horst, The Netherlands), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days prior to the start of dosing

ENVIRONMENTAL CONDITIONS
- Temperature (°C):22 +/- 2°C
- Humidity (%): 45-65 %
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 20.07. To: 17.08.2011

Vehicle:

acetone/olive oil (4:1 v/v)

Concentration:

10%, 25%, 50%

No. of animals per dose:

4

Details on study design:

RANGE FINDING TESTS:
- Compound solubility: The highest test item concentration, which can be technically used was a 50 % solution in actone:olive oil (4+1).
At hogher concentrations, an applicable formulation of the test item was not achieved, neither by the use of other vehicle nor by using additional methods to formulate the test item (e.g. vortexing, sonicating, warming to 37°C)
- Irritation: performed on two female mice, by topical application of concentrations of 25, and 50 % on each ear each on three consecutive days. Prior to application of the test item and before sacrifice the body weight was determined. Clinical signs were recorded at least once daily. Eventual signs of local skin irritation were documented and a score was used to grade a possible reddening of the ear skin. Furthermore, prior to application of the test item (day 1), on day 3 and before sacrifice (day 6) the ear thickness was determined using a micrometer. Additionally, for both animals, the ears were punched after sacrifice (day 6) at the apical area using a biopsy punch and were immediately pooled per animal and weighed using an analytical balance.
The animals did not show any signs of systemic toxicity. On day 3 to 6 the animal treated with 50% showed an erythema of the ear skin (day 3: Score 2, day 4 to 6: score 1). On day 3, the animal treated with 25% test item concentration showed an erythema of the skin (score: 1). Thus, the test item in the main study was assayed at 10, 25 and 50%. The highest level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation in the pre-experiment.

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: The sensitivity and reliability of the experimental technique employed was assessed by use of a
substance which is known to have skin sensitisation properties in CBA/CaOlaHsd mice (α-Hexylcinnamaldehyde in acetone:olive oil, 4:1 )

TREATMENT PREPARATION AND ADMINISTRATION:
25 µl was spread to the entire dorsal surface of each ear of each mouse once daily for three consecutive days. On day 6 an injection of 250 µl phosphate buffered saline (PBS) containing 19.9 µCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours
later, the draining Auricular lymph node of each ear was excised and pooled per group (8 nodes per group) into PBS. A single cell suspension of lymph node cells was prepared from each group. After washing two times with phosphate buffered saline the lymph node cells were resuspended in 5 % trichloroacetic acid and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid and transferred to plastic scintillation vials. The level of 3HTdR incorporation was then measured on a ß-scintillation counter.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

The mean values and standard deviations were calculated.

Positive control results:

The sensitivity and reliability of the experimental technique employed was assessed by use of Hexylcinnaldehyde which is known to have skin sensitisation properties in CBA/CaOlaHsd mice.
The EC3 value was calculated to be 10.4%.

Parameter:

SI

Remarks on result:

other: see Remark

Remarks:

Stimulation Indices (S.I.) of 1.11, 1.19 and 1.49 were determined with the test item at concentrations of 10, 25, 50 % in acetone: olive oil (4+1), respectively. The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.

Parameter:

other: disintegrations per minute (DPM)

Remarks on result:

other: Please refer to Table 1.

Table 1: Calculation and Results

Vehicle: acetone:olive oil (4+1 v/v)

Test item concentration % (w/w)	Group	Measurement DPM	Calculation			Result
			DPM-BG^a)	number of lymph nodes	DPM per lymph node^b^)	S.I.
---	BG I	15	---	---	---	---
---	BG II	16	---	---	---	---
0	1	1458	1443	8	180.3	1.00
10	2	1610	1595	8	199.3	1.11
25	3	1739	1724	8	215.4	1.19
50	4	2159	2144	8	267.9	1.49

BG =  Background (1 ml 5% trichloroacetic acid) in duplicate

1    =  Control Group

2-4=  Test Group

S.I. =  Stimulation Index

^a)   =  The mean value was taken from the figures BG I and BG II

^b)    =  Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled

The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

The test item was found to be not a skin sensitiser under the described conditions.

Executive summary:

The sensitization potential was investigated according to OECD Guideline 429.

The test item concentrations choosen for the LLNA test were 10, 25, 50 %.

No deaths occurred during the study period. No systemic findings were observed during the study period.The body weight of the animals was within the range commonly recorded for animals of this strain and age. On days 3 and 4, the animals treated with a test item concentration of 50% showed an erythema of the ear skin (day 3: Score 2, day 4 Score 1)

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

No deaths occurred during the study period. No systemic or local findings were observed during the study period. The body weight of the animals was within the range commonly recorded for animals of this strain and age. On days 3 and 4, the animals treated with a test item concentration of 50% showed an erythema of the ear skin (day 2: score 2, day 4: score 1).

Migrated from Short description of key information:
The sensitization potential Hostavin 3206 was investigated according to OECD Guideline 429. The test item concentrations chosen for the LLNA test were 10, 25, 50 %.

Justification for selection of skin sensitisation endpoint:
Guideline-conform study under GLP without deviations.

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

Hostavin 3206 did not show skin sensitizing properties in the Local Lymph Node Assay according to the current OECD guidelines. Allergic skin reactions or case reports of acute contact dermatitis to Hostavin 3206 have not been described in the literature. Therefore, the substance does not have to be classified as a skin sensitizer.